Merck and HAPPYneuron partner to include cognitive remediation program in Multiple Sclerosis e‑Health Solution

MS_Mood-CognitionMer­ck KGaA In Deal With HAP­PYneu­ron To Offer E‑Health Solu­tion For MS Patients (Nas­daq):

Ger­man drug mak­er Mer­ck KGaA (MKGAY.PK) announced Mon­day that it has entered into an agree­ment with HAP­PYneu­ron, a sub­sidiary of SBT Group of France, in which Mer­ck will receive an exclu­sive license to the com­pa­ny’s cog­ni­tive reme­di­a­tion train­ing pro­gram for peo­ple liv­ing with mul­ti­ple scle­ro­sis or MS. Finan­cial terms of the deal were not disclosed.

HAP­PYneu­ron’s cog­ni­tive reme­di­a­tion pro­gram will be avail­able for inclu­sion in Mer­ck­’s Msdi­a­log plat­form for use with Rebif (inter­fer­on beta-1a)…when deemed ben­e­fi­cial for a patient by his/her health­care provider. HAP­PYneu­ron is designed to improve cog­ni­tive skills through brain train­ing by repeat­ed cog­ni­tive game train­ing exercises…

MSdi­a­log is a mul­ti-ten­ant cloud-based soft­ware sys­tem for the man­age­ment of MS that cap­tures and presents patient out­come data to enable bet­ter deci­sion-mak­ing by patients and providers. MSdi­a­log is cur­rent­ly avail­able in 24 countries.”

To learn more:

About SharpBrains

SHARPBRAINS is an independent think-tank and consulting firm providing services at the frontier of applied neuroscience, health, leadership and innovation.
SHARPBRAINS es un think-tank y consultoría independiente proporcionando servicios para la neurociencia aplicada, salud, liderazgo e innovación.

Top Articles on Brain Health and Neuroplasticity

Top 10 Brain Teasers and Illusions

Newsletter

Subscribe to our e-newsletter

* indicates required

Got the book?